ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady wins RSNA Medal

January 12, 1990

In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says

November 25, 1977

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

NCI Puts Aside Fear Of Brockovich Factor To Open New Web Site On Mortality Data.

April 20, 2001